We are live on ! Find out more
ED

Exane Derivatives Portfolio holdings

AUM $174M
1-Year Est. Return 7.84%
This Fund
S&P 500
This Quarter Est. Return
+3.23%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
AUM
$906M
AUM Growth
+$185M
Cap. Flow
+$148M
Cap. Flow %
16.31%
Top 10 Hldgs %
24.88%
Holding
586
New
69
Increased
148
Reduced
238
Closed
71

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$23.7M
2
DB icon
Deutsche Bank
DB
+$15.9M
3
UNH icon
UnitedHealth
UNH
+$14.4M
4
COR icon
Cencora
COR
+$13.9M
5
OCR
OMNICARE INC
OCR
+$13.7M

Sector Composition

Rank Sector Weight
1 Industrials 17.33%
2 Consumer Discretionary 11.57%
3 Healthcare 7.92%
4 Utilities 7.88%
5 Materials 6.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EMB icon
51
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.9B
$3.31M 0.37%
29,501
+3,411
+13% +$379K
VALE icon
52
Vale
VALE
$62.3B
$3.13M 0.34%
+553,263
New +$4.01M
UBS icon
53
CALL
UBS Group
UBS
$170B
$3.09M 0.34%
17,991
+5,136
+40% +$89.4K
AMZN icon
54
Amazon
AMZN
$2.44T
$2.81M 0.31%
151,120
+118,940
+370% +$2.09M
B
55
Barrick Mining
B
$60.9B
$2.79M 0.31%
250,833
-11,508
-4% -$136K
ANF icon
56
Abercrombie & Fitch
ANF
$4.55B
$2.66M 0.29%
120,648
+88,849
+279% +$2.19M
TS icon
57
Tenaris
TS
$28.2B
$2.54M 0.28%
90,560
+18,081
+25% +$516K
EEM icon
58
iShares MSCI Emerging Markets ETF
EEM
$27.5B
$2.52M 0.28%
+62,845
New +$2.5M
YPF icon
59
YPF
YPF
$19.7B
$2.2M 0.24%
80,152
+29,785
+59% +$768K
CPA icon
60
Copa Holdings
CPA
$5.56B
$2.04M 0.23%
20,203
+6,310
+45% +$685K
MSFT icon
61
Microsoft
MSFT
$2.9T
$2M 0.22%
49,232
+19,075
+63% +$830K
AXP icon
62
American Express
AXP
$224B
$1.99M 0.22%
25,484
+23,983
+1,598% +$1.99M
ED icon
63
Consolidated Edison
ED
$41.4B
$1.95M 0.22%
31,969
-1,792
-5% -$116K
ALU
64
DELISTED
Alcatel-Lucent
ALU
$1.95M 0.22%
522,689
-1,227,146
-70% -$4.51M
BCE icon
65
CALL
BCE
BCE
$20.8B
$1.89M 0.21%
6,555
+1,600
+32% +$71.3K
BCS icon
66
Barclays
BCS
$87.8B
$1.82M 0.2%
134,226
+45,156
+51% +$633K
USO icon
67
CALL
United States Oil Fund
USO
$2.15B
$1.81M 0.2%
1,375
+437
+47% +$62.9K
EWP icon
68
iShares MSCI Spain ETF
EWP
$2.04B
$1.79M 0.2%
51,339
+31,652
+161% +$1.07M
BAC icon
69
Bank of America
BAC
$429B
$1.76M 0.19%
114,085
+64,728
+131% +$1.04M
C icon
70
Citigroup
C
$213B
$1.73M 0.19%
33,635
-76,239
-69% -$3.88M
APC
71
DELISTED
Anadarko Petroleum
APC
$1.67M 0.18%
20,180
+864
+4% +$70.7K
JNK icon
72
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$7.05B
$1.6M 0.18%
13,615
-1,248
-8% -$146K
ELD icon
73
WisdomTree Emerging Markets Local Debt Fund
ELD
$141M
$1.6M 0.18%
+40,274
New +$1.64M
GPRO icon
74
GoPro
GPRO
$120M
$1.56M 0.17%
36,005
+31,105
+635% +$1.47M
LVS icon
75
Las Vegas Sands
LVS
$31.4B
$1.46M 0.16%
+26,570
New +$1.48M

Similar funds

Exane Derivatives's Q1 2015 Portfolio in Review

As of Q1 2015, Exane Derivatives held 586 positions worth $906M, up 26% from $721M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Exane Derivatives deployed $148M of net new capital in Q1 2015, opening 69 new positions and adding to 148 existing holdings. Its largest new stake was WEC Energy: 438,756 shares worth $21.7M.

By sector, the portfolio is most concentrated in Industrials at 17% of assets, up from 6.6% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $23.7M trimmed.

  • Exane Derivatives's largest Q1 2015 buy was WEC Energy: 438,756 shares worth $21.7M.
  • Exane Derivatives added most to Delta Air Lines in Q1 2015, an estimated $23.1M increase.
  • Exane Derivatives's biggest Q1 2015 reduction was Vertex Pharmaceuticals, cutting an estimated $23.7M.
  • Exane Derivatives fully exited O'Reilly Automotive in Q1 2015, selling an estimated $13.3M.
  • Exane Derivatives's ten largest holdings make up 25% of its $906M portfolio in Q1 2015.
  • Exane Derivatives opened 69 new positions and closed 71 in Q1 2015.
  • Exane Derivatives's portfolio value rose 26% quarter-over-quarter to $906M.

Based on Exane Derivatives's 13F filing for Q1 2015, filed 15 May 2015.